Systemic lupus erythematosus
Conditions
Interventions
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Comply with the 2019 EULAR/ACR SLE classification standards; 2. Those who meet the TCM syndrome differentiation of heat toxin, blood stasis and kidney deficiency; 3.7 <= SLEDAI-2000 <=12 points and the current glucocorticoid dosage (calculated by prednisone) <= 1 mg/kg.d; 4. Those between the ages of 18 and 60; 5. Those who voluntarily participate in this trial and agree to sign the informed consent for entering the clinical research.
Exclusion criteria
Exclusion criteria: 1. Neuropsychiatric lupus patients or lupus crisis patients; 2. Patients with severe diseases of target organs of various systems, mental illness, tumors and other diseases; 3. Patients who cannot tolerate the drug treatment of this study; 4. Pregnant and lactating women; 5. Patients who are participating in other clinical trials; 6. The researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systemic lupus erythematosus disease activity score; | — |
Secondary
| Measure | Time frame |
|---|---|
| LupusQoL quality of life;Number of severe infections;TCM syndrome score;Changes of biomarker indicators before and after treatment; | — |
Countries
China
Contacts
Public ContactWen Chengping
Zhejiang Chinese Medical University
Outcome results
None listed